Prognostic significance of the thymidine phosphorylate/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer.
Kodama
Junichi
J
Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan. kodama@cc.okayama-u.ac.jp
Shinyo
Hasengaowa
H
Kusumoto
Tomoyuki
T
Seki
Noriko
N
Nakamura
Yojiro
Y
Nakamura
Keiichiro
K
Hongo
Atsushi
A
Hiramatsu
Yuji
Y
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000201:enzymology* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D015331:Cohort Studies; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000032:analysis / Q000378:metabolism*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric; D015996:Survival Rate; D013939:Thymidine Phosphorylase / Q000032:analysis / Q000378:metabolism*; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000201:enzymology* / Q000401:mortality / Q000473:pathology / Q000601:surgery
D014408:Biomarkers, Tumor; D042943:Dihydrouracil Dehydrogenase (NADP); D013939:Thymidine Phosphorylase